# A Pharmacokinetic/Pharmacodynamic Study of Eurartesim Dispersible Formulation in Infants With P.Falciparum Malaria

> **NCT01992900** · PHASE2 · COMPLETED · sponsor: **sigma-tau i.f.r. S.p.A.** · enrollment: 300 (actual)

## Conditions studied

- Malaria,Falciparum

## Interventions

- **DRUG:** Eurartesim dispersible oral tablet
- **DRUG:** eurartesim film coated tablet

## Key facts

- **NCT ID:** NCT01992900
- **Lead sponsor:** sigma-tau i.f.r. S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2015-07
- **Final completion:** 2016-01
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2016-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01992900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01992900, "A Pharmacokinetic/Pharmacodynamic Study of Eurartesim Dispersible Formulation in Infants With P.Falciparum Malaria". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01992900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*